[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371248-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371248-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-efficacy-of-sijunzi-on-immune-function-in-patients-with-gastrointestinal-cancers-after-surgery-integrating-systematic-review-and-network-pharmacology","The efficacy of Sijunzi on immune function in patients with gastrointestinal cancers after surgery - Integrating systematic review and network pharmacology","","Patients with gastrointestinal cancer often develop impaired immune function after surgery, prompting evaluation of Sijunzi decoction (SJZD) as an adjunct therapy. Electronic databases (CNKI, Wanfang, SinoMed, Weipu, PubMed, Web of Science, EMBASE, Cochrane) were searched through March 1, 2024 for randomized controlled trials. Thirteen RCTs with 1010 patients were meta-analyzed. SJZD plus conventional therapy improved CD3+ and CD4+ T lymphocytes, altered the CD4+/CD8+ ratio, and reduced CD8+ T lymphocytes. Evidence quality was low to very low, and network pharmacology suggested immune microenvironment regulation; additional high-quality RCTs are needed.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-efficacy-of-sijunzi-on-immune-function-in-patients-with-gastrointestinal-cancers-after-surgery-integrating-systematic-review-and-network-pharmacology/371248/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-efficacy-of-sijunzi-on-immune-function-in-patients-with-gastrointestinal-cancers-after-surgery-integrating-systematic-review-and-network-pharmacology/371248.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What immune problems do patients with gastrointestinal cancer face after surgery?","Question",{"text":63,"@type":64},"After surgery, patients with gastrointestinal cancer often show impaired immune function, including difficulty maintaining nutrition and weakened anabolism.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study evaluate the efficacy of Sijunzi decoction?",{"text":68,"@type":64},"The study used a systematic review and meta-analysis of randomized controlled trials, assessing methodological quality with the Cochrane risk of bias tool and synthesizing data with Review Manager 5.3. It also incorporated network pharmacology to explore potential mechanisms.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main meta-analysis findings for SJZD plus conventional therapy?",{"text":72,"@type":64},"SJZD combined with conventional therapies improved CD3+ and CD4+ T lymphocytes, increased the CD4+/CD8+ ratio, and reduced CD8+ T lymphocytes compared with conventional therapies alone.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371248,1790334518,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","®  \nSystematic Review and Meta-Analysis   \nThe efficacy of Sijunzi on immune function inpatients with gastrointestinal cancers after surgery  \nIntegrating systematic review and network pharmacology  \nZhulin Wu, MDa , Weiqing Zhang, MDa , Wangdong Miao, MMa , Siyi Li, PhDa , Jing Xie, MMa , Wensong Lu, MMa , Yuting Yan, MMa , Lisheng Peng, MMb , Weijun Luo, MDa ,*  \n\n| Abstract\u003Cbr>Background: Patients with gastrointestinal cancer often have impaired immune function after surgery. This study aimed to assess the efficacy of Sijunzi decoction (SJZD) on immune function in patients with gastrointestinal cancers after surgery. Methods: The electronic databases, including CNKI, Wanfang, SinoMed, Weipu, PubMed, Web of Science, EMBASE, and Cochrane databases were retrieved (March 1, 2024), and the randomized controlled trials (RCTs) that met the criteria were included. Methodologic quality assessment of RCTs was performed using the Cochrane risk of bias tool. The data of RCTs were acquired and analyzed by meta-analysis by Review Manager 5.3, and the quality of the evidence followed the Grading of Recommendations, Assessment, Development and Evaluations approach. This research was registered in the International Platform of Registered Systematic Review and Meta-analysis, 202440001. Based on the network pharmacology, relationships between key genes of SJZD and tumor-infiltrating immune cells in gastrointestinal cancers were explored.\u003Cbr>Results: Thirteen articles (RCTs) were included, containing 1010 patients with gastrointestinal cancers after surgery. The results of meta-analysis revealed that SJZD with conventional therapies could improve CD3+ T lymphocyte (mean difference [MD] = 5.73, 95% confidence interval [CI]: 2.07–9.39, P = .002), CD4+ T lymphocyte (MD = 5.86, 95% CI: 3.90–7.82, P \u003C .00001), CD4+/CD8+(MD = 0.29, 95% CI: 0.15–0.43, P \u003C .0001), and reduce CD8+ T lymphocyte (MD = −2 .44, 95% CI: −4.03 to −0 .85, P = .003) compared with conventional therapies alone. In addition, the funnel plot showed the included RCTs might have publication bias. The Grading of Recommendations, Assessment, Development and Evaluations classification showed low-quality evidence for CD4+ , CD8+ , and CD4+/CD8+ , and very low-quality evidence for other indicators. The network pharmacology results suggested that SJZD may exert effects by regulating the immune cells in the microenvironment of gastrointestinal cancers.\u003Cbr>Conclusion: SJZD could enhance the immune function of patients with gastrointestinal cancers after surgery. Due to the low quality of articles, more high-quality RCTs are needed to improve the level of evidence.\u003Cbr>Abbreviations: ALB = albumin, CI = confidence interval, HIFIA = hypoxia-inducible factor 1 subunit alpha, MD = mean difference, NK = natural killer, PPI = protein−protein interaction, SJZD = Sijunzi decoction, RCT =randomized clinical trial, TCM = traditional Chinese medicine, TIMER = Tumor Immune Estimation Resource tool. |\n| --- |\n| Keywords: compound decoction, gastrointestinal cancers, immune, randomized controlled trials, TCM |\n\n1. Introduction  \nGastrointestinal cancers are a huge global health problem worldwide.[1] Gastrointestinal cancers mainly consist of esophageal cancer, gastric cancer, and colorectal cancer, and previous  \nresearch showed that gastrointestinal cancers are commonly identified as the leading causes of cancer deaths.[2] Surgery isan important treatment method for gastrointestinal cancers, but patients often have impaired immune function, difficulty in eating, and weakened anabolism after gastrointestinal surgery.[3]  \nThis study was supported by the Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen (2024049) and the Medical Research Project of Shenzhen Longhua Medical Association (2023LHMA02). The authors have no conflicts of interest to disclose.  \nThe datasets generated during and/or analyzed during the current study are publicly available.  \nSupplemental ","cbCaii78Gq7A306u","https://ap.wps.com/l/cbCaii78Gq7A306u","pdf",2728539,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What immune problems do patients with gastrointestinal cancer face after surgery?\",\"answer\":\"After surgery, patients with gastrointestinal cancer often show impaired immune function, including difficulty maintaining nutrition and weakened anabolism.\"},{\"question\":\"How did the study evaluate the efficacy of Sijunzi decoction?\",\"answer\":\"The study used a systematic review and meta-analysis of randomized controlled trials, assessing methodological quality with the Cochrane risk of bias tool and synthesizing data with Review Manager 5.3. It also incorporated network pharmacology to explore potential mechanisms.\"},{\"question\":\"What were the main meta-analysis findings for SJZD plus conventional therapy?\",\"answer\":\"SJZD combined with conventional therapies improved CD3+ and CD4+ T lymphocytes, increased the CD4+/CD8+ ratio, and reduced CD8+ T lymphocytes compared with conventional therapies alone.\"}]","The efficacy of Sijunzi on immune function in patients with gastrointestinal cancers after surgery - Integrating systematic review and network pharmacology | PDF",1790191616,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/697599a492fa14099aa4d4397e568732.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64e6cec493e5501425c598182dac6cf5.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f37440d778ef5021d8514f6b87faee4f.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1bc55d8f4feb5ff8d14b7b9d2aef183.webp",980,1306]